Glybloc 25mg Tablet
Prescription Required
Product introduction
Glybloc 25mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels in your body after each meal. It is used when other similar medicines along with a restricted diet, are unable to control abnormally high blood sugar levels.
Glybloc 25mg Tablet is a medicine used in the treatment of type 2 diabetes mellitus. It should be taken just before meals as it lowers the post-meal blood sugar levels. This prevents the long-term complications of diabetes mellitus. Use of Glybloc 25mg Tablet along with a proper diet and exercise results in better blood sugar control. Initially, it may cause side effects such as stomach pain, bloating, and gas, but these get better with time.
Glybloc 25mg Tablet is a medicine used in the treatment of type 2 diabetes mellitus. It should be taken just before meals as it lowers the post-meal blood sugar levels. This prevents the long-term complications of diabetes mellitus. Use of Glybloc 25mg Tablet along with a proper diet and exercise results in better blood sugar control. Initially, it may cause side effects such as stomach pain, bloating, and gas, but these get better with time.
Uses of Glybloc Tablet
Benefits of Glybloc Tablet
In Treatment of Type 2 diabetes mellitus
Glybloc 25mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Glybloc 25mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Glybloc 25mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Glybloc Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glybloc
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Glybloc Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glybloc 25mg Tablet is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Glybloc 25mg Tablet.
Pregnancy
SAFE IF PRESCRIBED
Glybloc 25mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Glybloc 25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
SAFE
Glybloc 25mg Tablet does not usually affect your ability to drive.
Kidney
CAUTION
Glybloc 25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glybloc 25mg Tablet may be needed. Please consult your doctor.
Use of Glybloc 25mg Tablet is not recommended in patients with severe kidney disease.
Use of Glybloc 25mg Tablet is not recommended in patients with severe kidney disease.
Liver
SAFE IF PRESCRIBED
Glybloc 25mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Glybloc 25mg Tablet may not be needed in these patients. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Glybloc 25mg Tablet
₹5.12/Tablet
Mignar 25 Tablet
Glenmark Pharmaceuticals Ltd
₹16.07/tablet
214% costlier
Misobit 25 Tablet
Lupin Ltd
₹12.57/tablet
146% costlier
Minerva 25mg Tablet
Orchid Chemicals & Pharmaceuticals Ltd
₹5.03/tablet
2% cheaper
Euglitol 25mg Tablet
Abbott L
₹5/tablet
2% cheaper
Miglit 25mg Tablet
Biocon
₹5.92/tablet
16% costlier
Quick tips
- Glybloc 25mg Tablet lowers your post-meal blood sugar levels. Therefore, it should be taken before meals.
- Side effects such as stomach pain, gas, and diarrhea may occur during the first few weeks of treatment but should get better with time.
Fact Box
Chemical Class
Desoxynojirimycin Derivative
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Action Class
Alpha-glucosidase inhibitors
Patient concerns
FAQs
Is Glybloc 25mg Tablet safe?
Yes, Glybloc 25mg Tablet is relatively safe if used at prescribed doses for the prescribed duration as advised by your doctor
How does Glybloc 25mg Tablet work?
Glybloc 25mg Tablet belongs to the class of anti-diabetic drugs called alpha-glucosidase inhibitor. It blocks an enzyme known as ?-glucoside hydrolase and thus delays glucose absorption from intestine, thereby reducing the excessive rise in blood sugar level after a meal.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Powers AC, D’Alessio D. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1264.
- Nolte MS. Pancreatic hormones and antidiabetic drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 743-44.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 919-920.
- Miglitol. Leverkusen, Germany: Bayer HealthCare AG; 2018. [Accessed 12 Mar. 2019] (online) Availble from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Miglitol. [Updated 2018 Oct 31]. [Accessed 18 Feb. 2020] (online) Available from:
Marketer details
Name: Torrent Pharmaceuticals Ltd
Address: Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
22 people viewed this recentlyMRP
₹51.22
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT